ArticleReproductive medicine and biology2015
Cabergoline administration prevents development of moderate to severe ovarian hyperstimulation syndrome and it contributes to reduction in ovarian volume.
Tomoko Inoue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.